Hennion & Walsh Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Sell |
168,324
-30,869
| -15% | -$432K | 0.1% | 276 |
|
|
2025
Q1 | $2.69M | Sell |
199,193
-11,706
| -6% | -$158K | 0.12% | 212 |
|
|
2024
Q4 | $4.04M | Buy |
210,899
+13,498
| +7% | +$259K | 0.18% | 134 |
|
|
2024
Q3 | $4.49M | Buy |
197,401
+18,546
| +10% | +$422K | 0.21% | 111 |
|
|
2024
Q2 | $2.33M | Buy |
178,855
+69,035
| +63% | +$898K | 0.12% | 226 |
|
|
2024
Q1 | $1.92M | Buy |
109,820
+34,040
| +45% | +$596K | 0.1% | 264 |
|
|
2023
Q4 | $1.65M | Buy |
75,780
+48,668
| +180% | +$1.06M | 0.09% | 283 |
|
|
2023
Q3 | $416K | Buy |
27,112
+12,807
| +90% | +$196K | 0.03% | 571 |
|
|
2023
Q2 | $340K | Buy |
+14,305
| New | +$340K | 0.02% | 615 |
|